Fundraising Fox

Kisojibiotech

2 known investors

KisoJi Biotechnology discovers and develops differentiated antibody therapeutics targeting difficult targets in oncology and other diseases. Its platform combines proprietary multi-species single domain antibody transgenic mice, AI-enabled antibody fingerprinting, and multi-specific antibody engineering for therapeutic, diagnostic, and vaccine development.

AI & Machine LearningBiotechDeep Tech

Investors · 2

Lumira VenturesToronto · $1M – $10M
Remiges Ventures, Inc.Seattle

Competitors · 1

by search overlap
BDC Capital3 shared keywordsBusiness Development Bank of Canada (BDC) provides financing, advisory services, and educational resources to Canadian entrepreneurs and small and medium-sized businesses. It offers loans, working capital, and tailored support programs, including dedicated resources for Black, Indigenous, and women entrepreneurs.

Companies competing with Kisojibiotech for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Kisojibiotech do?
KisoJi Biotechnology discovers and develops differentiated antibody therapeutics targeting difficult targets in oncology and other diseases. Its platform combines proprietary multi-species single domain antibody transgenic mice, AI-enabled antibody fingerprinting, and multi-specific antibody engineering for therapeutic, diagnostic, and vaccine development.
Who are Kisojibiotech's investors?
Kisojibiotech's investors include Lumira Ventures, Remiges Ventures, Inc..